1. Erythromycin can affect bacterial protein synthesis and is generally effective against Gram-positive bacteria. It is mainly used to treat infections caused by penicillin G-resistant Staphylococcus aureus.
2. Erythromycin is a commonly used macrolide antibiotic with a similar antibacterial spectrum to penicillin. It is mainly used for penicillin-allergic patients or penicillin-resistant Staphylococcus aureus infections, and can also be used for streptococcus and pneumococcal infections and diphtheria carriers.
3. This product is a macrolide antibiotic derivative intermediate, which is a bacteriostatic antibiotic, and its antibacterial spectrum is similar to that of penicillin.